MD
Department of Blood Coagulation, Ogikubo Hospital, Tokyo, Japan
Dr. Azusa Nagao, M.D., M.Sc., is a distinguished hematologist currently serving at Ogikubo Hospital in Tokyo, Japan, which is renowned as the largest hemophilia treatment center in the country. With a focus on clinical research, Dr. Nagao has made significant contributions to the fields of women and girls' bleeding disorders, aging-related problems in hemophilia patients, and musculoskeletal ultrasound systems. As a testament to her dedication to aging-related problems in hemophilia patients, Dr. Nagao also serves as the principal investigator for ADVANCE Japan, a 10-year prospective registry study examining these issues.
In 2023, Dr. Nagao completed a short-term research fellowship at the prestigious Hemophilia and Thrombosis Treatment Center at the University of California, San Diego, enhancing her expertise in the field. Despite being an early-career investigator, she has already authored and co-authored over 20 scientific publications and has been invited as a speaker at numerous national and international meetings and congresses, showcasing her exceptional research capabilities and dedication to advancing hematology.
This impressive background not only reflects Dr. Nagao's commitment to her field but also her potential to continue making impactful contributions to the study and treatment of hemophilia and bleeding disorders worldwide.
Monday, July 11, 2022
6:30 PM – 7:30 PM
Monday, July 11, 2022
6:30 PM – 7:30 PM